Mathison J C, Ulevitch R J, Fletcher J R, Cochrane C G
Am J Pathol. 1980 Nov;101(2):245-64.
To examine the role of complement (C3) in determining the fate of lipopolysaccharide (LPS) in vivo, the distribution of LPS was studied in normocomplementemic (NC) and C3-depleted animals (pretreated with cobra venom factor [CoF]) after intravenous injection of highly purified, radioiodinated Salmonella minnesota R595 LPS. After injection of a lethal (250 micrograms) or nonlethal (5 micrograms) dose of LPS in NC and CoF rabbits and a lethal (5 mg/kg) dose of LPS in rhesus monkeys, the LPS disappeared from blood in a biphasic manner. In all cases, a substantial portion of the dose was removed from blood in an initial disappearance phase (t1/2 < 15 minutes), which, in some cases, was accelerated in CoF-treated animals. LPS remaining in blood beyond 30 minutes persisted with a much increased half-life (> 5 hours). Liver contained the major portion (40%) of tissue-bound LPS (determined by use of 131I-BSA blood marker) in animals killed 3--5 hours after injection. The distribution of LPS in rabbits was found to be dose-indpendent and only minimally changed by prior depletion of C3. In addition, the tissue distribution and cellular localization of LPS in monkeys was similar to that we have reported previously for R595 LPS in NC rabbits and was not substantially changed by prior CoF treatment. These results indicate that binding of C3 to intravenously injected LPS is not required for the initial rapid disappearance from blood. Further, the uptake of LPS by cellular targets, notably the hepatic macrophages (Kupffer cells), is not altered by in vivo decomplementation.
为研究补体(C3)在体内决定脂多糖(LPS)命运中的作用,在静脉注射高度纯化的、放射性碘化的明尼苏达沙门氏菌R595 LPS后,研究了正常补体血症(NC)动物和C3缺失动物(用眼镜蛇毒因子[CoF]预处理)中LPS的分布。在给NC和CoF处理的兔注射致死剂量(250微克)或非致死剂量(5微克)的LPS以及给恒河猴注射致死剂量(5毫克/千克)的LPS后,LPS以双相方式从血液中消失。在所有情况下,相当一部分剂量在初始消失阶段(t1/2 < 15分钟)从血液中清除,在某些情况下,CoF处理的动物中这一过程加速。30分钟后仍留在血液中的LPS持续存在,半衰期大大延长(> 5小时)。在注射后3 - 5小时处死的动物中,肝脏含有组织结合LPS的主要部分(40%)(通过使用131I - BSA血液标志物测定)。发现兔体内LPS的分布与剂量无关,并且C3预先缺失对其影响极小。此外,猴体内LPS的组织分布和细胞定位与我们先前报道的NC兔中R595 LPS的情况相似,并且预先的CoF处理并未使其发生实质性改变。这些结果表明,静脉注射的LPS从血液中最初的快速消失并不需要C3与之结合。此外,细胞靶点,尤其是肝巨噬细胞(库普弗细胞)对LPS的摄取在体内补体缺失时并未改变。